Educational Disclaimer: This library is curated for licensed medical professionals and is for informational purposes only. Inclusion of a study does not constitute endorsement of clinical application. All citations link directly to peer-reviewed sources on PubMed or publisher websites. The evidence base for many regenerative applications is still maturing; practitioners should apply professional judgment and consult current FDA guidance.
Exosome Biology and Mechanism
Foundational research establishing the biological properties, characterization methods, and therapeutic potential of MSC-derived exosomes. These references provide the mechanistic basis for clinical research across all application areas.
Clinical applications of stem cell-derived exosomes.
Tan F, et al. Signal Transduction and Targeted Therapy. Jan 2024;9:17.
Exosome Source Matters: A Comprehensive Review from the Perspective of Diverse Cellular Origins.
Chen Y, et al. Pharmaceutics. Feb 2025;17(2):147.PMC11858990
Clinical Frontiers of Exosome Research: A Comprehensive Analysis of Human Trials.
Mohan S, et al. Journal of Pharmacology and Pharmacotherapeutics. 2025.
Therapeutic potential of MSC-derived exosomes.
Harrell CR, et al. Clinical and Experimental Medicine. Mar 2024.PMC10907468
Dermatological Applications
Research examining exosome and biologic applications in skin biology, wound healing, and dermatological procedures. The evidence base is predominantly preclinical and early-phase; large controlled trials in aesthetic dermatology are still maturing.
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Skin Wound Healing.
Shao S, et al. Frontiers in Bioengineering and Biotechnology. 2021;9:654927.PMC8065628
Biogenesis of extracellular vesicles: exosomes, microvesicles, and retrovirus-like vesicles.
Akers JC, et al. Virology. 2013;441(1):40-49.PMC5029103
Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine.
Nikfarjam S, et al. Journal of Translational Medicine. 2020;18(1):449.PMC10907468
Hair Restoration and Alopecia
Research on PRP and emerging exosome applications in hair follicle biology, androgenetic alopecia, and dermal papilla cell signaling. PRP has the most established human clinical trial support; exosome research in this area is growing but predominantly preclinical.
Platelet-rich plasma for androgenetic alopecia: a systematic review and meta-analysis.
Gupta AK, et al. Journal of the American Academy of Dermatology. 2019;82(5):1154-1161.PMC6122524
Wnt signaling in hair follicle development and regeneration.
Lim X, Bhatt D. Cold Spring Harbor Perspectives in Biology. 2013.PMC3646437
Exosome Source Matters: Therapeutic Potential in Hair Follicle Biology.
Witwer KW, et al. Pharmaceutics. 2025;17(2):147.PMC11858990
Sports Medicine and Orthopedic Applications
Research on PRP and regenerative biologic applications in tendon, ligament, and joint biology. PRP has the longest orthopedic clinical track record. MSC-derived exosomes are an emerging area with growing preclinical support in musculoskeletal research.
Platelet-Rich Plasma: A Short Overview of Certain Bioactivities and Clinical Implications in Regenerative Medicine.
Everts PA, et al. Journal of Clinical Medicine. 2017;6(5):55.PMC5449664
Sports medicine applications of platelet rich plasma.
Mishra A, et al. Current Pharmaceutical Biotechnology. 2010;11(2):185-190.PMC3108991
Platelet-Rich Plasma: The PAW Classification System.
DeLong JM, et al. Arthroscopy. 2012;28(7):998-1009.PMC3463288
Platelet-Rich Plasma: Intra-Articular Knee Injections Produced Favorable Results on Degenerative Cartilage Lesions.
Kon E, et al. Knee Surgery, Sports Traumatology, Arthroscopy. 2010;18(4):472-479.PMC5806188
Compounding Pharmacy and Regulatory Context
Reference material on 503A/503B compounding regulatory frameworks, cGMP standards, and the FDA oversight structure for biologics and compounded preparations relevant to regenerative medicine supply chains.
Guidance for Industry: Current Good Manufacturing Practice Requirements for Combination Products.
FDA. FDA Guidance Documents. 2015 (Updated 2017).
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) from Adipose Tissue: Regulatory Considerations; Guidance for Industry.
FDA. FDA Guidance Documents. 2022.
Longevity Medicine and Functional Biology
Research relevant to biohacking coaches and longevity practitioners, covering NAD+ metabolism, hallmarks of aging, cellular senescence, and the mechanistic rationale for regenerative interventions in functional medicine contexts.
The Hallmarks of Aging.
Lopez-Otin C, et al. Cell. 2013;153(6):1194-1217.
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.
Yoshino J, et al. Cell Metabolism. 2018;27(3):513-528.
Senolytic drugs: from discovery to translation.
Kirkland JL, Tchkonia T. Journal of Internal Medicine. 2020;288(5):518-536.
Source the Biologics Behind the Research
ExaVeyra Sciences supplies NPI-verified practitioners with cGMP exosomes, peptides, PRP kits, and GLP-1 compounding supplies.